drugset
Drugs / CampETEC HBC
last change Jun 2025 re-read 3 minutes ago

CampETEC HBC

also known as CampETEC Hyperimmune Bovine Colostrum · HBC

Protein / enzyme biologic

Investigated by
Henry M. Jackson Foundation for the Advancement of Military Medicine · Johns Hopkins Bloomberg School of Public Health · Naval Medical Research Center · United States Department of Defense

Trials 1

today NCT06122870 · Ph 1
202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06122870 Dec 2023 → Jun 2024 — Johns Hopkins Bloomberg School of Public Health Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CampETEC HBC ClinicalTrials.gov intervention name — accepted as the source's own label NCT06122870 ↗
Known as CampETEC Hyperimmune Bovine Colostrum “CampETEC Hyperimmune Bovine Colostrum (HBC)” NCT06122870 ↗
Known as HBC “CampETEC Hyperimmune Bovine Colostrum (HBC)” NCT06122870 ↗
Modality Protein / enzyme biologic “serum-derived bovine immunoglobulins” NCT06122870 ↗
Route Oral “when orally administered” NCT06122870 ↗